Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693209010 | Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693211018 | Erythromycin 40 mg/g and tretinoin 250 microgram/g cutaneous solution | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | est un(e) (attribut) | Erythromycin and tretinoin only product in cutaneous dose form | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Erythromycin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has basis of strength substance (attribute) | Tretinoin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has basis of strength substance (attribute) | Erythromycin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | microgram (qualifier value) | true | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Tretinoin (substance) | true | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | est un(e) (attribut) | Product containing erythromycin in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | est un(e) (attribut) | Product containing tretinoin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | a pour principe actif (attribut) | Erythromycin (substance) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | a pour principe actif (attribut) | Skin agent (substance) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | a pour principe actif (attribut) | Tretinoin (substance) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | est un(e) (attribut) | Product containing erythromycin and tretinoin (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | a pour principe actif (attribut) | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | a une forme pharmaceutique (attribut) | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | a une forme pharmaceutique (attribut) | Solution | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | a une forme pharmaceutique (attribut) | Cutaneous solution | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | est un(e) (attribut) | Product containing tretinoin in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator value (attribute) | 250 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has basis of strength substance (attribute) | Tretinoin (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Count of base of active ingredient | deux | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Erythromycin (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator value (attribute) | 40 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength numerator unit | microgram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has basis of strength substance (attribute) | Erythromycin (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely erythromycin 40 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous solution (clinical drug) | Has precise active ingredient | Tretinoin (substance) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR